#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Methylmalonic acidaemia Adenocarcinoma pancreas Adrenoleukodystrophy Non-Hodgkin's lymphoma PIK3CA related overgrowth spectrum Gaucher's disease type III Astrocytoma malignant Thermal burn Thalassaemia Penile squamous cell carcinoma Cystic fibrosis respiratory infection suppression Glomerulonephritis membranoproliferative Prodromal Alzheimer's disease Ductal adenocarcinoma of pancreas Primary mediastinal large B-cell lymphoma More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Life with Disease Retinoblastoma – Trials in Disease Nephrotic syndrome – Life with Disease Pulmonary fibrosis Fragile X syndrome – Basic Information Rhabdomyosarcoma recurrent VEXAS syndrome – Treatment Hereditary motor and sensory neuropathy – Trials in Disease Short-bowel syndrome – Trials in Disease Rhabdomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tyrosine Protein C Olorofim Mebeverine Hydrochloride Trastuzumab Emtansine Oseltamivir Cariprazine Padeliporfin Anhydrous Cidofovir Mcla-129 Methotrexate Sodium Ivacaftor Obinutuzumab Follitropin Beta Etamsylate Givinostat Protein S Piromelatine Bay 2927088 Emraclidine More therapies…

    Learn about Your Condition

    Syphilis Procedural haemorrhage Anorexia nervosa Postpartum haemorrhage Gastrointestinal carcinoma Malabsorption Osteosarcoma metastatic Rectal cancer recurrent Chronic granulomatous disease Dermatitis atopic Alcoholic liver disease Bipolar I disorder Open angle glaucoma Amnestic disorder Gestational diabetes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of isatuximab, belumosudil and dexamethasone combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Belumosudil Mesilate
    • Isatuximab
    • Dexamethasone
    France Germany Greece Italy Norway Portugal

  • Study on the Effect of Atorvastatin in Slowing Down Arrhythmogenic Cardiomyopathy Progression in Patients with the Condition

    Recruiting

    2 1 1
    Investigated Diseases:
    • Arrhythmogenic right ventricular dysplasia
    Investigated Drugs:
    • Atorvastatin
    Italy

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Breast cancer recurrent
    • Breast cancer stage IV
    Investigated Drugs:
    • Ds-3939A
    Belgium France Spain

  • Study on Oxaliplatin with Drug Combination for Patients with Advanced Peritoneal Metastasis from Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Panitumumab
    • Bevacizumab
    • Capecitabine
    France

  • Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Norway

  • Evaluation of Contrast-Enhanced Spectral Mammography Using Iopromide in Women with Suspicious Breast Lesions to Improve Diagnostic Accuracy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Iopromide
    Italy
Previous Page
1 … 610 611 612 613 614 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!